Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to affect short-term and long-term outcomes such as cardiopulmonary health after PE needs “better characterisation”, Akhilesh...
Daniel Clair (Columbia, SC, USA), presented positive six-month data from the full patient cohort of the PROMISE I early feasibility study of the LimFlow percutaneous deep vein arterialisation system (LimFlow) as a late-breaking trial at VIVA 2019 (Vascular InterVentional...
Curiously, the mortality risk for patients with critical limb ischaemia (CLI) has not changed over the last few decades, despite advances in cardiovascular medicine that treat myocardial infarction and stroke, the two biggest causes of death in these patients,...
Bruce Gray (Greenville, USA) talks to Vascular News after winning the LIVE (Leader In EndoVascular Education) award at VIVA 2019 (4–7 November, Las Vegas, USA), which he says was “very humbling” and “an honour”. Gray speaks to the challenge of...
Nick Hopkins (Buffalo, USA) talks to BLearning Neuro at VEITH Symposium 2018 (13–17 November 2018, New York, USA) about the DAWN trial (LINK), which showed that in carefully selected acute ischaemic stroke patients that “intervention out to 24 hours is viable”. “Stroke...
Philippe Kolh (Liege, Belgium) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about how the European Society for Vascular Surgery’s (ESVS) plans to disseminate the recently published Global Vascular Guidelines for Chronic Limb Threatening...
 The GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System was launched in the USA at the 2019 SVS Vascular Annual Meeting (VAM; 12–15 June 2019, National Harbor), just weeks after the device obtained FDA approval. Dittmar Böckler (Heidelberg,...
Christian-Alexander Behrendt (Hamburg, Germany) talks to BLearning Peripherial at ESVS 2019 (European Society of Vascular Surgery; 24-27 September 2019; Hamburg, Germany) about an international study that underlines the stark difference between the number of major amputations in countries like Hungary and Slovakia and others,...
Kevin Mani (Uppsala, Sweden) talks to BLearning Aortic at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about a recently published epidemiological analysis of ruptured abdominal aortic aneurysms (AAAs) in Sweden over a twenty-year period. The analysis indicated that the epidemiology of ruptured AAAs is...
Bijan Modarai (London, UK) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about the HT-CLI trial, which will look at the efficacy of a novel blood filtration technology that is aimed at using cells that are...
Jos van den Berg (Lugano, Switzerland) tells Vascular News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of using the APERTO drug-coated balloon (DCB; Cardionovum) in haemodialysis patients who had stenosis of, mainly, de novo...
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular...
Lorenzo Patrone (London, UK) shares with BLearning at CIRSE 2019 (7–11 September, Barcelona, Spain) the benefits of using the OUTBACK™ Elite Re-entry Catheter (Cordis, a Cardinal Health Company) in chronic total occlusions—in any arterial segment from the iliacs to...
NOTE: ONLY intended for healthcare professionals outside of the USA and France. Zoom in on a tête-à-tete between Marianne Brodmann (Graz, Austria) and Giovanni Torsello (Munster, Germany) who talk through the latest clinical evidence that directly compares drug-eluting stents in...
NOTE: ONLY intended for healthcare professionals outside of the USA. Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the EFFPAC trial and the six-month outcomes of the TINTIN trial. Both trials used the luminor...
NOTE: This video is ONLY available to watch in selected countries and geographies   Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New Zealand) to distil the headline findings from the first-ever results of the IN.PACT AV access...
 Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain. Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...
Ali Azizzadeh (Los Angeles, USA) talks to BLearning at SVS 2019 (Society for Vascular Surgery, 12–15 June, Washington DC, USA) about his recent move from Houston, Texas to Los Angeles, California, and how the patient populations differ between these two areas. Azizzadeh has observed...
 Ian Loftus (London, UK), president of the Vascular Society for Great Britain and Ireland, tells BLearning about the most recent developments in the UK’s NICE guidance on abdominal aortic aneurysm. The draft version of the guideline created a furore, when...
𝙏𝙝𝙞𝙨 𝙫𝙞𝙙𝙚𝙤 𝙞𝙨 𝙞𝙣𝙩𝙚𝙣𝙙𝙚𝙙 𝙛𝙤𝙧 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙞𝙣 𝙀𝙪𝙧𝙤𝙥𝙚 𝙤𝙣𝙡𝙮. Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is why, they say,...
Jos van den Berg (Lugano, Switzerland), Antonio Micari (Bergamo, Italy) and Marianne Brodmann (Graz, Austria) sit down after a specially convened US FDA panel reviewed paclitaxel device data, with recommendations still to come. The physicians discuss the safety of...
Rajesh Dave (Camp Hill, USA) talks to iWounds News about his highlights from the 15th annual C3 conference, which included a special session on the paclitaxel controversy. Dave talks about the “journey of 15 years” and how the meeting started...
Mahmoud Malas (San Diego, USA) presented, for the first time, updated results from the TransCarotid Artery Revascularization (TCAR) Surveillance Project at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM; 12–15 June, National Harbor, USA). Malas distilled the data...
Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration. Hayes...
 Health technology solutions—such as mobile apps and wearables—can play a huge role in activity tracking and assessing the outcomes of peripheral vascular interventions, says Ronald L Dalman (Stanford, USA), president-elect of the Society for Vascular Surgery (SVS). Down the...
 Kim Hodgson (Springfield, USA), president of the Society for Vascular Surgery (SVS) for 2019–20 spoke to Vascular News at the organisation’s Vascular Annual Meeting in June to share the most influential data to have emerged from the Vascular Quality...
 Dawn Coleman (Ann Arbor, USA) shares headline findings from a Society for Vascular Surgery (SVS) survey that found 41% of 960 respondents met validated metrics for burnout. “Burnout, depression and suicidal ideation represent a very real problem within our...
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about...
 Watch the video roundup from the CX 2019 Highlight Session, Paclitaxel: The last word. Filmed onsite at the Charing Cross Symposium (15–18 April 2019, London, UK).
Ulf Teichgräber (Jena, Germany), talks to Vascular News at EuroPCR 2019 about the EFFPAC trial which compared the luminor (iVascular) drug-coated balloon (DCB) with plain old balloon angioplasty (POBA). Teichgräber outlines the 24-month results from the trial specifically the secondary...
Eluvia DES is the only technology that uses polymer-based drug delivery to treat Peripheral Artery Disease (PAD). Its polymer ensures that the majority of drug is delivered to the tissue while minimizing downstream particulates. Boston Scientific has more than...
 Following the latest information presented at the Charing Cross (CX) International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they...
 At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in...
 There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel: The Last Word. The session also emphasised the need for a meta-analysis of individual patient-level data...
This post is sponsored by iVascular  Interview with Vicente Riambau (Hospital Clinic de Barcelona, Spain) about the paclitaxel matter. Are really all the drug-coated balloons the same?
This post is sponsored by iVascular Interview with Koen Deloose (AZ Sint-Blasius, Belgium) about paclitaxel safety and the outcomes of Luminor in different types of lesions.
 Jan Blankensteijn (Amsterdam, The Netherlands; principal investigator of the DREAM trial) tells Vascular News about what inspired him to design the DREAM trial, how its findings became particularly important with the long-term follow-up data for endovascular aneurysm repair (EVAR)...
 Roger Greenhalgh (London, UK), was honoured at the 2018 VEITHsymposium alongside other endovascular aneurysm repair (EVAR) pioneers. He spoke to Vascular News about his conviction in the late 1990s that prospective randomised controlled trials were the way to properly...
 "Paclitaxel kills the cells in the artery wall; sirolimus simply stuns them," says Peter Gaines (Sheffield, UK). Gaines commented at the 2019 Vascular Leaders Forum (VLF; 1–2 March, Washington, DC, USA) on the modes of action of these two...
 Krishna Rocha-Singh (Springfield, USA) tells Vascular News that plans after VLF 2019 include publishing a white paper and expeditiously pooling individual patient-level data from the industry randomised controlled trials for independent statistical analysis. This analysis would validate, or disprove,...
 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists should be using best medical therapy “more than we do ”. He also shares his...
 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in treatment of pulmonary embolism, acute and chronic deep venous thrombosis (DVT) using acoustic pulse thrombolysis. This...
 Marianne Brodmann (Graz, Austria) quizzes Michael Lichternberg (Arnsberg, Germany) at LINC 2019 on his choice of tools to identify and repair dissections in both the superficial femoral artery and below the knee. If there is dissection that shows a haemodynamic...
 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and trials in the space and the lack of long-term evidence showing AVFs created percutaneously “are still...
 Jihad Mustapha (Grand Rapids, USA) explains how the Temporary Spur stent system (Reflow), which is a spiked self-expanding stent is intended for use in conjunction with a drug-coated balloon, works to help deliver drug to the media or subintima...
 In the arterial space, VIVA 2018 focused on the fact that there is an increasing awareness of limb threatening ischaemia coupled with an increase in interventional tools, but no clear defined pathway for treatment. There is also uncertainty about...
 Dierk Scheinert (Leipzig, Germany) talks to Vascular News at LINC 2019 about the importance of vessel preparation with adjunctive therapies such as the use of the dedicated scoring balloon, ULTRASCORE (BD), prior to the use of a drug-coated balloon...
 Renowned experts expressed confidence in the continued use of paclitaxel-coated devices after independent patient-level data presented at LINC 2019 did not show correlation between paclitaxel exposure and mortality. Findings from Baim (formerly Harvard Clinical Research Institute) are now published in...
 Recent technological advancements, including the use of micromesh stents, greater adoption of proximal protection and new techniques such as transcarotid artery revascularisation (TCAR) are taking the field of carotid artery stenting (CAS) forward. A major advance will be getting reimbursement...
 Sean Lyden (Cleveland, USA) and Fabrizio Fanelli (Rome, Italy) discuss the safety and future of drug-coated balloons (DCB) in light of the latest pooled analysis of patient-level data of over 2,300 patients treated with Philips’ Stellarex DCB in above-the-knee...
 A renowned panel, moderated by Dierk Scheinert (Leipzig, Germany), comprising Peter Schneider (Honolulu, USA), John Laird (St Helena, USA) and Thomas Zeller (Bad Krozingen, Germany) expressed confidence in the continued use of paclitaxel-coated devices after individual patient-level data were...
 Ross Milner (Chicago, USA) spoke to Vascular News at the VEITHsymposium about the importance of long-term data for aortic endografts and the GREAT (Global Registry for Endovascular Aortic Treatment) study—a 5,000 patient real-world dataset that will follow patients out to...
 Stéphan Haulon, member of the CX Aortic Executive Board looks ahead to CX 2019 and raises some of the key questions that will be addressed in the programme.
 The draft Global Vascular Guidelines on chronic limb threatening ischaemia (CLTI) have just been posted for open public comment until 3 December 2018. Michael S Conte (San Francisco, USA), one of the co-editors of the guidelines, told Vascular News...
 Artificial intelligence (AI) is already better than humans at reading specific radiographic findings. It will impact phycisians’ jobs, but because it can currently only do very specific things, it is not yet “that robot chasing you down a dark...
Michael Jaff (Newton, USA) outlines the major recent developments in best medical therapy that will impact the treatment of peripheral arterial disease (PAD) at VEITHsymposium 2018.
 Patrick Geraghty (St Louis, USA) presented new datapoints from the six-month outcomes of the Lutonix BTK IDE trial at the 2018 VEITHsymposium (13–17 November, New York, USA). In addition to the positive safety and efficacy data that were presented...
 Tilo Kölbel (Hamburg, Germany, and co-director of Aortic Live) tells Vascular News about the recently installed fusion imaging system from Cydar Medical, which connects live images from the operating room to the power of cloud computing. Kölbel shares his...
Six-month outcomes of the Lutonix BTK IDE trial, a multicentre randomised controlled trial using the Lutonix 014 drug-coated balloon (DCB; BD), has demonstrated that the DCB is safe and effective to use for the treatment of narrowed or obstructed...
Stéphan Haulon (Université Paris Sud, France) tells Vascular News at Aortic Live 2018 in Essen, Germany, about a niche group of patients, i.e., those that have had prior open repair of the ascending aorta following an acute type A dissection, that are...
Thomas Zeller (Bad Krozingen, Germany) delves into data and design of the TOBA II (Tack Optimized Balloon Angioplasty II) trial with principal investigator William Gray (Philadelphia, USA) for Vascular News. Gray, who presented the one-year findings of TOBA II...
 “The best treatment for a 60-year-old man with an infrarenal abdominal aortic aneurysm that is above the threshold for intervention is arguably surgery based on the durability of this intervention. However, operating at this age (where open surgery is...
 Rachel Bell (Guy’s and St Thomas’ Hospital, London, UK) describes a variety of specialist surgical options to treat infection after endovascular aneurysm repair (EVAR), a relatively rare occurrence that can have devastating complications. She stresses the importance of dealing...
 Ronald L Dalman (Stanford, USA), vice president of the Society for Vascular Surgery, discusses how aligning an individual surgeon’s goals with those of the institution at which he/she is sited is important to counter the “epidemic” of burnout. Dalman...
 Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also called Lithoplasty) seeks to microfragment the calcium seen in the vessels of peripheral arterial disease...
 Andrew Klein (a consultant anaesthetist from Royal Papworth hospital in Cambridge, UK) tells Vascular News that research in cardiac surgery has shown that while the surgeon has a small, but important, effect on a patient’s outcome after surgery, it is the...
 Chronic exposure to low dose radiation, such as that experienced by operators who routinely perform endovascular aneurysm repair (EVAR), has biological effects that can be mitigated with the use of lead shielding for the legs. However, many vascular and...
 “The instructions for use (IFU) are not a clinical guideline, so trainees should really think about what the main considerations are when they are implanting devices in the aorta to create a durable repair,” said Tara Mastracci (Royal Free...
 Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to real-world outcomes of using Lutonix DCB in AV access. Straight after the presentation, Steinke tells Vascular News about...
Andrew Holden (Auckland, News Zealand) interviews Stefan Mueller-Huelsbeck (Flensburg, Germany) to distil the key findings of the IMPERIAL trial one-year data that were presented for the very first time at CIRSE 2018 in Lisbon. In the randomised controlled trial, Eluvia,...
Tilo Kölbel (University Heart Center Hamburg, Germany) talks about the findings of the STEP collaboration, and why endovascular procedure operators perhaps are "not the best people to examine neurological outcome" in their patients. STEP is a multidisciplinary initiative which aims...
Sean Lyden of the Cleveland Clinic (Cleveland, USA) discusses Endologix' Ovation grafts and the use endovascular aneurysm repair (EVAR) in short neck and complex anatomies.
Marc Schermerhorn (Boston, USA) discusses the three-year results of an analysis on the long-term survival of Nellix EVAS system (Endologix) IDE trial patients vs. a cohort of EVAR patients. The study found that EVAS is associated with higher long-term...
Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Colin Bicknell (Imperial College, London, UK) speaks to Vascular News about his experience of using EndoAnchors in thoracic endovascular aortic repair (TEVAR), sharing his tips and techniques.
Maria Antonella Ruffino spoke to Vascular News at LINC 2018 about the differences between mesh-covered stents and conventional devices in treatment of carotid artery disease, as well as the differences between currently available mesh-covered stents.
Andrew Holden spoke to Vascular News at LINC 2018 (Leipzig Interventional Course; 30 January–2 February, Leipzig, Germany) about the new data from the IN.PACT AV access trial and its significance, as well as Holden's experience with the drug-coated balloon...
Vascular News interviews Panos Kitrou, Patras University Hospital, Rio, Greece, on the interim data from the LUTONIX DCB AV registry trial. The data were presented at the Leipzig Interventional Course 2018 (LINC; 30 January-2 February, Leipzig, Germany). https://www.youtube.com/watch?v=g1xN3knVdw4  
At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips' Atul Gupta (Global Chief Medical Officer, Image Guided Therapy) and Will Martin (Peripheral Segment Leader, Image Guided Therapy) to...
Vascular News interviews Fabrizio Fanelli, Rome, Italy, on the results of the IN.PACT Admiral drug-coated balloon (Medtronic) in long lesions, lesions with calcification, chronic total occlusions, and TASC C and D lesions. The data were presented at the Charing...
This year Gore is celebrating 20 years of experience and innovation in the aortic space. At the Charing Cross Symposium (25–28 April, London, UK) Michael Dake, Stanford, USA, spoke to Vascular News about this milestone and about how Gore...
At the 2017 Charing Cross Symposium (25–28 April, London, UK) Klaus Amendt presented six-month outcomes from the all-comers LOCOMOTIVE Registry, which is investigating the use of the VascuFlex Multi-LOC multiple stent delivery system (B Braun). Amendt explained to Vascular...
The Charing Cross Symposium 2017 held a special session on Thursday 27 April to remember Edward B Diethrich, who died in February. The cardiovascular surgeon, who was one of the endovascular pioneers, was the founder of the Arizona Heart...
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system...
At LINC 2017 Vascular News spoke to Peter Schneider (Kaiser Foundation Hospital, Honolulu, Hawaii, USA) about the Tack endovascular system (Intact Vascular), an implant designed to repair dissection damage done to the arterial wall during angioplasty treatment with minimal stress to the...
At LINC 2017 (24–27 January, Leipzig, Germany), Luis Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented an update on the SUPERSUB trial, which is investigating the use of the Supera stent (Abbott Vascular) for subintimal recanalisation in critical...
The LUMINOR Registry is a real-world prospective multicentre study evaluating iVascular’s Luminor paclitaxel-eluting balloon for treating advanced limb ischaemia. Vascular News spoke to Vincent Riambau (Autonomous University of Barcelona, Barcelona, Spain), who presented an update on the Registry at...
The first US randomised controlled trial for drug-coated balloon use for arteriovenous fistula obstructions for 50 years, the Lutonix (Bard) IDE trial was a talking point of the 2017 LINC meeting (24–27 January, Leipzig, Germany). Scott Trerotola, who presented...
At LINC 2017 (24–27 January, Leipzig, Germany), Sean Lyden (Cleveland Clinic, Cleveland, USA) presented an update on the 12-month results of the European and US cohorts of the ILLUMENATE randomised controlled trials, which are investigating the use of the Stellarex...
Piotr Szopinski, Institute of Haematology and Transfusion Medicine, Warsaw, Poland, speaks to Vascular News at the 2016 VEITHSymposium about the development and use of the COLT endograft system (Jotec) for the treatment of thoracoabdominal aortic aneurysm. ...
Vascular News speaks to Mario Lachat, University of Zurich, Zurich, Switzerland, at the 2016 VEITHSymposium, about the concepts behind the Horizon and Nexus stent grafts (Endospan) and whether these translate to clinical success. ...
Michael Lichtenberg, Klinikum Arnsberg, Arnsberg, Germany, tells Vascular News about the Wingman CTO catheter—a new chronic total occlusions recanalisation device from ReFlow Medical used to cross long and difficult occlusions—explaining how it works, when it is suitable, and his...
Speaking to Vascular News, Tej Singh, El Camino Hospital, Mountain View, USA, discusses the new vascular flow device from Medistim, explaining why there is a need for a new intraoperative arterial flow measurement system and how its use has...
Santi Trimarchi, University of Milan, Policlinico San Donato IRCCS, Milan, Italy speaks to Vascular News at the 2016 VEITHsymposium about the latest data from the IRAD (International Registry of Acute Aortic Dissection) Registry, how to manage in-hospital complications in type...
In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses the progress of the IMPERIAL trial comparing the Eluvia (Boston Scientific) and Zilver PTX (Cook...
  Andrew Holden (Auckland City Hospital, Auckland, New Zealand) is one of the principal investigators of the Nellix EVAS FORWARD Global Registry. He explained to Vascular News what to consider when selecting abdominal aortic aneurysm patients for Nellix treatment, why...
Matt Thompson (Chief Medical Officer, Endologix) speaks to Vascular News about what plans he has in his new role and the place of the Endologix portfolio in the physician’s armamentarium. He also tells Vascular News where he sees Nellix...
  Speaking to Vascular News at the 2016 VEITHsymposium, Bob Mitchell (President, Endologix) discusses updated Nellix instructions for use and the potential of the endovascular aneurysm sealing (EVAS) system in chimney repair. Looking at the rest of the Endologix product...
Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted and how relevant it is for young and senior clinicians to present their research at...
Colin Bicknell, London, UK, interviews Matt Thompson, St George's Vascular Institute, London, UK, about EndoVascular Aneurysm Sealing (EVAS) and the one-year results from the EVAS FORWARD Global Registry with the Nellix device. https://youtu.be/ID-TxhwRfuY  
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX...
Janet Powell, Imperial College, London, UK, is interviewed about the 12-month results of the IMPROVE trial, presented for the first time at CX 2015. The study compares open repair and an endovascular strategy for ruptured abdominal aortic aneurysms. https://youtu.be/0mBE6_pHUtU
Colin Bicknell, London, UK, interviews Michael Dake, Stanford, USA, discussing the use of, and early results for, the new GORE TAG Thoracic Branch Endoprosthesis device. https://youtu.be/tjjOru2c-lk
Ian Loftus, London, UK, interviews Rodney White, Torrance, USA about new techniques for reconstruction of the ascending aorta, including White’s experience with a new endovascular device. https://youtu.be/sOuXIBxzjUo
This video tells the story of one of the world’s most prominent heart surgeons, Edward Diethrich, and the career-altering health issues he has faced as a result of chronic, low-level exposure to ionising radiation through his work. https://youtu.be/rXgt0bF3GJM
Lars Lönn carries out a thoracic endovascular aortic repair procedure on the Mentice VIST-Lab simulator. He presents a case and provides tips and tricks in endovascular practice. https://youtu.be/pAUqltrOMPQ
Vascular surgeon Peter Gloviczki explains who should be watched for abdominal aortic aneurysms, how they are diagnosed and how surgery, which now includes a less invasive endovascular option, is improving survival rates. https://youtu.be/JBJ-_olH67I
Frank Veith, chairman of the VEITHsymposium, speaks to Vascular News about the hot topics presented in the scientific sessions at the recent congress in New York and describes new technologies featured at the conference. https://youtu.be/pdByFKAufBk
Klaus Linni, Salzburg, Austria, spoke to Vascular News about the early results from a randomised trial comparing the use of a bioabsorbable stent vs. thrombendarterectomy for the treatment of common femoral artery lesions. The data were presented at the...
Haroun Gajraj, director of the The VeinCare Centre, Bristol, UK, speaks about using medical super glue for the treatment of varicose veins and superficial venous reflux.
Bruce Perler, professor of Surgery and vascular surgeon, John Hopkins Medicine, USA, speaks about the treatment options and preventative measures that can be taken in carotid artery disease and stroke patients. https://youtu.be/NE_ose_81Z0
Scott Stevens, Knoxville, USA, spoke about the durability of EVAR devices at the 35th CX Symposium (6-9 April 2013, London, UK). Stevens stated that going low profile should not compromise device performance. https://youtu.be/iEoG4kuI05Y
Zamaneh Kassiri, a professor in the Department of Physiology, University of Alberta, is investigating the role of a protein called TIMP3 in abdominal aortic aneurysms. https://youtu.be/AmeNAiGLXlk
https://youtu.be/ac_om5HCjvg
Patrick Peeters, chief Department Cardio-Vascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium, speaks about the right mix to make bioabsorbable drug-eluting stents, potential benefits, and challenges in the peripheral and coronary arteries treatment.   https://youtu.be/kS9IwwSU6eo

Ian Loftus

Alan Lumsden

Kim Hodgson